Cover Image

Advanced case of PKDL due to delayed treatment: A rare case report.

Post-kala-azar dermal leishmaniasis (PKDL) is clinical outcome of visceral leishmaniasis (VL) and is thought to be the potential reservoir of parasite. Miltefosine (MF) is the only oral drug existing for treatment of post-kala-azar dermal leishmaniasis (PKDL). Increased miltefosine tolerance in clin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Roshan Kamal Topno (Author), Vidya Nand Rabi Das (Author), Maneesh Kumar (Author), Major Madhukar (Author), Krishna Pandey (Author), Neena Verma (Author), Kanhaiya Agrawal (Author), Chandra Shekhar Lal (Author), Niyamat Ali Siddiqui (Author), Sanjiva Bimal (Author), Pradeep Das (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2020-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.
by: Vidya Nand Ravi Das, et al.
Published: (2016)

Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
by: Vidya Nand Rabi Das, et al.
Published: (2020)

A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
by: Vidya N, et al.
Published: (2008)

Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.
by: Vidya Nand Rabi Das, et al.
Published: (2021)

Viral Etiological Factors Causing Acute Encephalitis Syndrome (AES) In Gaya Division, India
by: Roshan Topno, et al.
Published: (2019)

Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal.
by: Anand Ballabh Joshi, et al.
Published: (2023)

Pharmacotherapeutic Options for Visceral Leishmaniasis-Current Scenario
by: Krishna Pandey MD, et al.
Published: (2009)

Impact of ASHA training on active case detection of visceral leishmaniasis in Bihar, India.
by: Vidya Nand Ravi Das, et al.
Published: (2014)

Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study.
by: Shyam Sundar, et al.
Published: (2014)

Snowball Vs. House-to-House Technique for Measuring Annual Incidence of Kala-azar in the Higher Endemic Blocks of Bihar, India: A Comparison.
by: Niyamat A Siddiqui, et al.
Published: (2016)

Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.
by: Dinesh Mondal, et al.
Published: (2010)

Kala-azar elimination in a highly-endemic district of Bihar, India: A success story.
by: Vijay Kumar, et al.
Published: (2020)

Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.
by: Sushmita Das, et al.
Published: (2016)

Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India.
by: Vishal Goyal, et al.
Published: (2020)

Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.
by: Ulrika Marking, et al.
Published: (2014)

Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.
by: Sauman Singh-Phulgenda, et al.
Published: (2024)

Diagnosis of visceral leishmaniasis in Bihar India: comparison of the rK39 rapid diagnostic test on whole blood versus serum.
by: Greg Matlashewski, et al.
Published: (2013)

Role of neutrophils in the pathogenesis of Post Kala-azar Dermal Leishmaniasis (PKDL).
by: Madhurima Roy, et al.
Published: (2024)

Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India.
by: Vishal Goyal, et al.
Published: (2018)

Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
by: Gajendra Kumar Katara, et al.
Published: (2012)

Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.
by: V Ramesh, et al.
Published: (2015)

Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.
by: V Ramesh, et al.
Published: (2015)

Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani.
by: Pradyot Bhattacharya, et al.
Published: (2016)

PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
by: Eduard E Zijlstra
Published: (2014)

PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.
by: Swagata Ganguly, et al.
Published: (2015)

Suicidal ideation associated with vitiligo - A systematic review of prevalence and assessment
by: Somanaboina Padmakar, et al.
Published: (2022)

Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India.
by: Vishal Goyal, et al.
Published: (2019)

Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients.
by: Gajendra Kumar Katara, et al.
Published: (2011)

Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.
by: Sarfaraz Ahmad Ejazi, et al.
Published: (2016)

Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs
by: Huda M, et al.
Published: (2012)

Combination Therapy for Post-Kala-Azar Dermal Leishmaniasis: A Literature Review of Current Evidence
by: Alka Kumari, et al.
Published: (2024)

A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh.
by: Shyam Sundar, et al.
Published: (2024)

Impediments of reporting dengue cases in India
by: Sushmita Das, et al.
Published: (2017)

Alopecia and Periodontitis: Exploring the connecting dots
by: Jaya Agrawal, et al.
Published: (2023)

Oncocytic Variant Of Medullary Thyroid Carcinoma - A Case Report
by: Srilatha P.S, et al.
Published: (2019)

Grade IV splenic injury: When to consult interventional radiology-a case report and review of management protocols
by: Madhukar Dayal, et al.
Published: (2024)

One More Death from Visceral Leishmaniasis Has Gone by Unnoticed. What Can Be Done?
by: Greg Matlashewski, et al.
Published: (2013)

Use of standardised patients to assess tuberculosis case management by private pharmacies in Patna, India: A repeat cross-sectional study.
by: Anita Svadzian, et al.
Published: (2023)

Multicentric reticulohistiocytosis: A case report with review
by: Vidya Kuntoji, et al.
Published: (2017)

Primary Hyperparathyroidism Presenting as Posterior Reversible Encephalopathy Syndrome: A Report of Two Cases
by: Rimesh Pal, et al.
Published: (2020)